Personalized cancer therapy, which provides tailored treatments based on a patient’s specific characteristics (e.g. genetic status), has shown great promise for improving outcomes for cancer patients. Meanwhile, hundreds of clinical trials are investigating drugs that target specific genetic alterations in tumors. A CLAMP based system was developed by Melax for extracting genetic alteration information for personalized cancer therapy from ClinicalTrials.gov.
top of page
bottom of page